Clinical Pharmacology Considerations for Peptide Drug Products
thought leadership
SEPTEMBER 20, 2023
The FDA has recently issued this draft guidance to address clinical pharmacology considerations for peptide drug products. These recommendations are within the framework of the existing regulations and reference several existing guidance documents as appropriate for both drugs and biologics.
Let's personalize your content